Moreno, Gabriel M <br/><br/>
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.  [electronic resource] 

 -  Neurology  10 2018 
 - 797-799 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0000000000006396  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antipsychotic Agents--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Parkinson Disease--complications<br/>Piperidines--therapeutic use<br/>Psychotic Disorders--drug therapy<br/>Quetiapine Fumarate--therapeutic use<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Urea--analogs & derivatives